← All trials
NCT06030258
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 30, 2023
- Primary completion
- Jan 24, 2025
- Completion date
- Oct 21, 2025
- First posted
- Sep 8, 2023
- Last posted
- Nov 21, 2023
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- InxMed (Shanghai) Co., Ltd.Lead sponsor
- Peking UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.